Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy - Archive ouverte HAL Access content directly
Journal Articles Critical Reviews in Oncology/Hematology Year : 2016

Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy

Abstract

18 F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) allows to quantify the metabolic activity of a tumor (glycolysis) and has become a reference tool in oncology for the staging, restaging, radiotherapy planning and monitoring response in many cancers. Quantitative analyses have been introduced in order to overcome some of the limits of the visual methods, allowing an easier and more objective comparison of the inter- and intra-patients variations. The aims of this review were to report available evidences on the clinical value of quantitative PET/CT parameters in HNC. Forty-five studies, for a total of 2928 patients, were analyzed. Most of the data available dealt with the intensity of the metabolism, calculated from the Standard Uptake Value (SUV). Metabolic Tumor Volume (MTV) was well correlated with overall survival and disease free survival, with a higher predictive value than the maximum SUV. Spatial distribution of metabolism and textural analyses seems promising.
Fichier principal
Vignette du fichier
Castelli et al. - Overview of the predictive value of quantitative 1.pdf (560.66 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01479228 , version 1 (18-07-2017)

Identifiers

Cite

J. Castelli, B. de Bari, A. Depeursinge, A. Simon, A. Devillers, et al.. Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy. Critical Reviews in Oncology/Hematology, 2016, 108, pp.40-51. ⟨10.1016/j.critrevonc.2016.10.009⟩. ⟨hal-01479228⟩
230 View
250 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More